Jamieson advised the management team of LGC, the international life sciences measurement and testing company, on its sale from its current owners Bridgepoint, to KKR.  KKR will partner with LGC to provide capital and operational support to facilitate future growth.

LGC provides a range of measurement products and services which underpin the safety, health and security of the public, including reference materials and proficiency testing, genomics reagents, instrumentation and services, and expert sample analysis and interpretation. The company serves customers across a number of end markets including pharmaceuticals, agricultural biotechnology, food, environment, government and academia.

LGC has grown impressively over the past 5 years through the significant investment support of Bridgepoint which has enabled, for example, the acquisition of 12 related companies and revenue growth from £130m in 2010 to £222m in 2015.  With the support of KKR, management plans to continue the rapid development of the business, building global leadership positions within their chosen markets, with a particular focus on the U.S and Asia.

The Jamieson team was led by Stuart Coventry, Andrew Cox and Fred Stonell.